Divi's Laboratories Limited

Price Chart

Risk-Adjusted Performance

Divi's Laboratories Limited (DIVISLAB) Price Performance

Divi's Laboratories Limited (DIVISLAB) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR6026.00, down 1.21% from the previous close.

Over the past year, DIVISLAB has traded between a low of INR5689.50 and a high of INR6883.50. The stock has lost 1.7% over this period. It is currently 12.5% below its 52-week high.

Divi's Laboratories Limited has a market capitalization of $1.67T, with a price-to-earnings ratio of 67.27.

About Divi's Laboratories Limited

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.